drugset / Trial / NCT01313702
Single Pill to Avert Cardiovascular Events
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether a polipill improved the compliance with treatment compared to usual care that use two or more drugs,in patients at high cardiovascular risk or previous cardiovascular disease.
Timeline
- Start
- 2012-10
- Primary completion
- 2014-04
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | — |
| Subject | Atenolol | Other / unclassified | 50 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 10 mg | — |
| Subject | Simvastatin | Small molecule | 40 mg | — |